Detecting oral abnormalities early leads to more treatment options, potentially less invasive or radical treatments and better patient outcomes.
Introducing the VELscope Vx Enhanced Oral Assessment System, which centers on a wireless, handheld scope that uses natural tissue fluorescence visualization to help discover oral mucosal abnormalities that might otherwise have been overlooked.
Cleared by the FDA and the World Health Organization, the award-winning VELscope Vx is the world’s most widely used adjunctive device for the discovery of:
Viral, fungal and bacterial infections
Inflammation from a variety of causes (allergy to amalgam fillings, etc.)
Salivary gland tumors
Cancer and pre-cancer
Other oral mucosal conditions
Traditional risk factors of
oral cancer include:
Previous history of oral cancer
Over 40 years of age
More than 25 million VELscope Vx examinations have been performed by over 12,000 dental practitioners in 23 countries. The technology is also backed by more clinical studies than any other adjunctive device for tissue fluorescence visualization.